Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | PKLR | P30613 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | COXFA4 | O00483 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5986967 | 0.81 | PKM (0.41) | PKMPKLRMAPTNPC1RAB9A | |
| SCHEMBL23423286 | 0.78 | PKM (0.41) | PKMPKLRSCN9AMAPTNPC1 | |
| SCHEMBL5308527 | 0.78 | NPC1 (0.43) | PKMPKLRMAPTNPC1RAB9A | |
| SCHEMBL3243563 | 0.77 | FTO (0.43) | PKMPKLRSCN9AMAPTNPC1 | |
| SCHEMBL23422992 | 0.72 | KDM1A (0.40) | PKMSCN9AMAPTNPC1RAB9A | |
| SCHEMBL23746308 | 0.72 | HTR2C (0.46) | PKMPKLRSCN9AMAPTNPC1 | |
| SCHEMBL6025550 | 0.72 | PKM (0.48) | PKMPKLRMAPTNPC1RAB9A | |
| SCHEMBL30888534 | 0.72 | MAPT (0.47) | PKMPKLRMAPTNPC1RAB9A | |
| SCHEMBL10754154 | 0.70 | MAPT (0.39) | PKMPKLRMAPTNPC1RAB9A | |
| SCHEMBL21994829 | 0.70 | AKR1B1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630403-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121129-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| EP-4156936-A1 | ACTIVE COMPOUND COMBINATIONS | Bayer Aktiengesellschaft (DE) | 2023-04-05 | — | — | EP | disclosed |